Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Medicine: ADP-A2M4CD8

Name: SURPASS-2: investing ADP-A2M4CD8 SPEAR T-cell therapy to treat esophageal and GEJ cancers
Uploaded: 2022-01-24T00:00:00Z
Duration: 4 min 10 s

Sorry, no posts matched your criteria.

Medicine: ADP-A2M4CD8

Cookie settings